Navigation Links
3M Withdraws Blackmail Claims Against Harvey Boulter From New York Court

LONDON, February 29, 2012 /PRNewswire/ --

In the latest development in an ongoing global legal dispute, 3M Company (3M) has withdrawn a lawsuit it filed in a New York court against Harvey Boulter, the CEO of investment fund manager Porton Group.

The termination of 3M's lawsuit in New York follows a decision earlier this month by a Washington DC federal judge ruling that 3M's "blackmail" claim against the Porton Group's Washington DC attorney was invalid.

3M's withdrawal of the case in New York also comes in the wake of Porton's victory in the High Court in London last November, where 3M was held liable for damages for breach of its contractual obligations over its failure to develop a test to track MRSA in hospitals after buying the base technology from a consortium led by Porton.

Porton Group CEO, Harvey Boulter, said: "I am delighted that 3M has withdrawn its New York lawsuit. 3M made unfounded accusations in the US designed to deflect attention from the case in the UK, where 3M was held liable for breach of contract.

"3M's spurious 'blackmail' claims had absolutely no merit. I am pleased that the New York case has been closed on this sham of a dispute."

The decision coincides with the departure of Sir George Buckley as President and CEO of 3M last week (24 February). The legal wrangle was ignited publically when 3M falsely alleged that Mr Boulter had threatened, after a meeting with the then UK Defence Secretary Liam Fox, to use political contacts to have Sir George stripped of his knighthood unless 3M paid Porton $30 million to settle the contract dispute.

Notes to Editors:

For further information please contact Eben Black on +44-7968-559-198 or or Anna Brown on +44-7834-570-464 or

This release supersedes that issued on the same subject on February 23.

SOURCE Porton Group
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. WHO Withdraws Notice of Concern for Mylans Matrix Unit
2. FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c
3. Universal Bioenergy, Inc. Expressly Disclaims Any Responsibility for the Content, Accuracy of Information, and Quality of Information Regarding Universal Published by Any Third-Party and Being Disseminated on the Internet
4. US Patent Office Rejects 95% of Verathon Claims in Patent Case With Aircraft Medical
5. Despite claims, UK did not gas Iraqis in the 1920s, new research finds
6. Lawsuit Claims Celgene Corporation Misappropriated the Idea Behind its Multiple Myeloma Treatments
7. The Medical College of Wisconsin Adopts Quantros Event Manager(TM) and Claims Manager(TM) for Comprehensive Malpractice Litigation Management
8. Despite claims, UK did not gas Iraqis in the 1920s, new research finds
9. Despite claims, UK did not gas Iraqis in the 1920s, new research finds
10. Academics Launch New Web Site Holding Jeffrey Smith's Claims on GM Foods Up to Peer-Reviewed Science
11. False Claims by Supporters Swirl Around Hayashi Bill
Post Your Comments:
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator (YI) ... of the Class of 2016 were selected from a pool of 128 applicants ... the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... OTTAWA, ON (PRWEB) , ... June 23, 2016 , ... ... former DNA Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA ... joining the STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. ...
(Date:6/23/2016)... June 23, 2016 ... 2016;12(1):22-8 Published recently ... peer-reviewed journal from touchONCOLOGY, Andrew D Zelenetz ... of cancer care is placing an increasing burden ... expensive biologic therapies. With the patents on many ...
Breaking Biology Technology:
(Date:6/9/2016)... attendance control systems is proud to announce the introduction of fingerprint attendance control software, ... employees are actually signing in, and to even control the opening of doors. ... ... ... Photo - ...
(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... Dollar project, for the , Supply and Delivery ... IT Infrastructure , to Decatur ... Identity Management Solutions. Numerous renowned international vendors participated in the ... was selected for the most compliant and innovative solution. The ...
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of the medical ... premium product recently added to the range of products distributed by Ampronix. ... ... ... Ampronix News ...
Breaking Biology News(10 mins):